JP2017501148A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501148A5 JP2017501148A5 JP2016538783A JP2016538783A JP2017501148A5 JP 2017501148 A5 JP2017501148 A5 JP 2017501148A5 JP 2016538783 A JP2016538783 A JP 2016538783A JP 2016538783 A JP2016538783 A JP 2016538783A JP 2017501148 A5 JP2017501148 A5 JP 2017501148A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- mixture
- conjugation
- chemical moiety
- reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 17
- 239000000203 mixture Substances 0.000 claims 16
- 235000018102 proteins Nutrition 0.000 claims 11
- 102000004169 proteins and genes Human genes 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 11
- 230000021615 conjugation Effects 0.000 claims 7
- 239000000126 substance Substances 0.000 claims 5
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 4
- 239000003638 chemical reducing agent Substances 0.000 claims 4
- 238000006722 reduction reaction Methods 0.000 claims 4
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 2
- 238000009295 crossflow filtration Methods 0.000 claims 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 2
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- 108010024636 Glutathione Proteins 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 229960002433 cysteine Drugs 0.000 claims 1
- 238000011026 diafiltration Methods 0.000 claims 1
- 239000012538 diafiltration buffer Substances 0.000 claims 1
- 229960003180 glutathione Drugs 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229960003151 mercaptamine Drugs 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13197150 | 2013-12-13 | ||
| EP13197150.9 | 2013-12-13 | ||
| PCT/EP2014/077777 WO2015086853A1 (en) | 2013-12-13 | 2014-12-15 | Method for thioether conjugation of proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017501148A JP2017501148A (ja) | 2017-01-12 |
| JP2017501148A5 true JP2017501148A5 (enExample) | 2018-01-25 |
| JP6603662B2 JP6603662B2 (ja) | 2019-11-06 |
Family
ID=49765887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538783A Active JP6603662B2 (ja) | 2013-12-13 | 2014-12-15 | タンパク質のチオエーテルコンジュゲーション方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11219690B2 (enExample) |
| EP (1) | EP3079722B1 (enExample) |
| JP (1) | JP6603662B2 (enExample) |
| CN (1) | CN106068127B (enExample) |
| ES (1) | ES2869309T3 (enExample) |
| WO (1) | WO2015086853A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117106085A (zh) | 2015-12-23 | 2023-11-24 | 美国安进公司 | 使用gipr结合蛋白与glp-1激动剂的组合来治疗或改善代谢病症的方法 |
| EP4480537A3 (en) | 2017-01-17 | 2025-03-12 | Amgen Inc. | Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr) |
| CA3062194A1 (en) | 2017-06-20 | 2018-12-27 | Amgen Inc. | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists |
| JP7250706B2 (ja) | 2017-06-21 | 2023-04-03 | アムジエン・インコーポレーテツド | 胃抑制ペプチド受容体（ｇｉｐｒ）に対するアンタゴニスト結合タンパク質／ｇｌｐ－１受容体アゴニスト融合タンパク質を使用した代謝障害の治療又は寛解方法 |
| MA68842B1 (fr) * | 2017-08-04 | 2025-01-31 | Amgen Inc. | Procédé de conjugaison de cys-mabs |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753165B1 (en) | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
| ATE375363T1 (de) | 1997-07-14 | 2007-10-15 | Bolder Biotechnology Inc | Derivate des wachstumshormons und verwandte proteine |
| AU775937B2 (en) * | 1999-01-14 | 2004-08-19 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
| NZ522847A (en) | 2000-05-16 | 2004-11-26 | Bolder Biotechnology Inc | Methods for refolding proteins containing free cysteine residues |
| WO2004101597A2 (en) | 2003-05-13 | 2004-11-25 | Frutarom Ltd. | Methods for the reduction of disulfide bonds |
| EP2033662B1 (en) | 2004-01-21 | 2012-10-17 | Novo Nordisk Health Care AG | Transglutaminase mediated conjugation of peptides |
| US8633300B2 (en) | 2005-06-17 | 2014-01-21 | Novo Nordisk Healthcare Ag | Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine |
| GB0513852D0 (en) | 2005-07-06 | 2005-08-10 | Celltech R&D Ltd | Biological products |
| WO2007109475A2 (en) * | 2006-03-16 | 2007-09-27 | Bracco Imaging S.P.A. | Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines |
| JP5703020B2 (ja) | 2007-08-24 | 2015-04-15 | ノボ ノルディスク ヘルス ケア アーゲー | タンパク質を選択的に修飾するための組成物と方法 |
| PL2525834T3 (pl) * | 2010-01-22 | 2020-10-19 | Novo Nordisk Health Care Ag | Hormony wzrostu o przedłużonej skuteczności in-vivo |
| RU2012134974A (ru) | 2010-01-22 | 2014-02-27 | Ново Нордиск Хелс Кеа Аг | Стабилизированное соединение гормона роста |
| ES2582590T3 (es) | 2010-02-16 | 2016-09-13 | Novo Nordisk A/S | Método de purificación |
| CN103269720A (zh) | 2010-07-22 | 2013-08-28 | 诺沃—诺迪斯克保健股份有限公司 | 生长激素缀合物 |
| EP3412314A1 (en) | 2011-05-27 | 2018-12-12 | Baxalta GmbH | Therapeutic proteins conjugated to polysialic acid and methods of preparing same |
| KR20140091721A (ko) * | 2011-11-02 | 2014-07-22 | 제넨테크, 인크. | 오버로드 및 용리 크로마토그래피 |
| CN103087183A (zh) | 2013-01-17 | 2013-05-08 | 南京邮电大学 | 一种光激发蛋白质中二硫键还原得到自由巯基的方法 |
-
2014
- 2014-12-15 EP EP14818938.4A patent/EP3079722B1/en active Active
- 2014-12-15 JP JP2016538783A patent/JP6603662B2/ja active Active
- 2014-12-15 US US15/103,482 patent/US11219690B2/en active Active
- 2014-12-15 ES ES14818938T patent/ES2869309T3/es active Active
- 2014-12-15 WO PCT/EP2014/077777 patent/WO2015086853A1/en not_active Ceased
- 2014-12-15 CN CN201480068335.5A patent/CN106068127B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2846598C (en) | Treatment of degenerative joint disease | |
| PE20091388A1 (es) | Moleculas y metodos para modular el componente de complemento | |
| TWI666026B (zh) | Ｗｔ１抗原胜肽結合疫苗 | |
| JP2015519313A5 (enExample) | ||
| BRPI0406800B1 (pt) | Dímero de peptídeo, composição farmacêutica contendo o mesmo e seu uso | |
| BR112018007960A2 (pt) | conjugado, proteína pcrv, composição imunogênica, métodos de preparação de uma composição imunogênica, de tratamento e de produção de um bioconjugado, polinucleotídeo, vetor, célula hospedeira, e, bioconjugado. | |
| WO2016130573A3 (en) | Degradable thiol-ene polymers and methods of making thereof | |
| RU2018122823A (ru) | Мутанты белка f rsv | |
| EP2189471A4 (en) | FOXM1 PEPTIDE AND MEDICAMENT THEREFOR | |
| JP2016512540A5 (enExample) | ||
| RU2016107873A (ru) | Пептиды | |
| JP6603662B2 (ja) | タンパク質のチオエーテルコンジュゲーション方法 | |
| Takeda et al. | Amphiphilic nanogel of enzymatically synthesized glycogen as an artificial molecular chaperone for effective protein refolding | |
| BR112017021016A2 (pt) | preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo | |
| ES2546758T3 (es) | Electroforesis con inmunodesplazamiento | |
| AU2020399030A1 (en) | Calcium-sensing receptor agonist compound and application thereof | |
| KR20110136504A (ko) | Ｒａｇｅ 수용체 표적 펩타이드에 약물을 결합시킨 것을 특징으로 하는 약물 복합체 | |
| JP2019503994A5 (enExample) | ||
| DK2289533T3 (da) | Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider | |
| JP5713006B2 (ja) | チオスルホナート化合物、タンパク質及び／又はペプチドの可逆的カチオン化剤並びに可溶化方法 | |
| JPWO2017154869A1 (ja) | 変異型ヒトエリスロポエチンの製造方法 | |
| JP2010006756A (ja) | 高分子量セリシン水溶液 | |
| WO2012053856A3 (ko) | 호흡기 신시치아 바이러스 백신 조성물 및 그의 제조방법 | |
| 田中克典 | A histological study of vasoconstrictive effect by epinephrine-containing local anesthetic in the jaw bone. | |
| US745333A (en) | Serum and process of preparing same. |